Fried Frank Reps Merck In $430M Inspire Deal
Merck & Co. Inc. on Tuesday announced plans to acquire North Carolina-based Inspire Pharmaceuticals Inc. for roughly $430 million, expanding its ophthalmology business and promising emerging treatments for eye diseases....To view the full article, register now.
Already a subscriber? Click here to view full article